Upregulation of enzymes metabolizing 5-fluorouracil in colorectal cancer

被引:15
|
作者
Matsusaka, Satoshi [1 ]
Yamasaki, Hajime [1 ]
Fukushima, Masakazu [1 ]
Wakabayashi, Ichiro [1 ]
机构
[1] Yamagata Univ, Sch Med, Dept Hyg & Prevent Med, Yamagata 9909585, Japan
关键词
colorectal cancer; 5-fluorouracil; lymph node metastasis; orotate phosphoribosyltransferase; ribonucleotide reductase;
D O I
10.1159/000098249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of this study was to compare the activities of various enzymes, participating in the metabolism of 5-fluorouracil, between colorectal cancer and nontumor tissues and to investigate the association of the enzyme activities with clinicopathological backgrounds. Methods: Activities of seven enzymes involved in nucleic acid metabolism - orotate phosphoribosyltransferase (OPRT), ribonucleotide reductase (RNR), thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, uridine phosphorylase and thymidine kinase (TK) - were measured in tumor and nontumor tissues from 28 patients who were operated on for colorectal cancers. Results: OPRT, thymidylate synthase, RNR, thymidine phosphorylase, uridine phosphorylase and thymidine kinase activities were significantly higher in tumor areas than in nontumor areas. OPRT showed the highest T/N ratio ( the ratio of each enzyme activity in tumor areas to that in nontumor areas). The T/N ratio of RNR activity showed a tendency to be associated with lymph node metastasis and Dukes classification. Conclusion: The results suggest that OPRT is a main enzyme participating in the phosphorylation of 5-fluorouracil and has an important role in tumor growth. The T/N ratio of RNR may be predictive of tumor progression. Copyright (c) 2007 S. Karger AG, Basel
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [41] INTRAPERITONEAL 5-FLUOROURACIL IN THE MANAGEMENT OF COLORECTAL LIVER-CANCER
    ANDERSSON, R
    HOLMBERG, A
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1992, 18 (02): : 152 - 155
  • [42] The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer
    Zalcberg, JR
    Siderov, J
    Simes, J
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 41 - 46
  • [43] Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer
    Zampino, MG
    Lorizzo, K
    Rocca, A
    Locatelli, M
    Zorzino, L
    Manzoni, S
    Mazzetta, C
    Fazio, N
    Biffi, R
    De Braud, F
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2425 - 2428
  • [44] INTRAPORTAL 5-FLUOROURACIL FOR COLORECTAL-CANCER - THE AXIS TRIAL
    GARTEN, L
    STENNING, S
    GRAY, R
    LANCET, 1992, 340 (8825): : 985 - 985
  • [45] Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer
    Punt, CJA
    SEMINARS IN ONCOLOGY, 2000, 27 (05) : 88 - 90
  • [46] Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer
    Kidd, EA
    Yu, JS
    Li, X
    Shannon, WD
    Watson, MA
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2612 - 2619
  • [47] Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer
    Gallant, Jean-Nicolas
    Allen, Joshua E.
    Smith, Charles D.
    Dicker, David T.
    Wang, Wenge
    Dolloff, Nathan G.
    Navaraj, Arunasalam
    El-Deiry, Wafik S.
    CANCER BIOLOGY & THERAPY, 2011, 12 (03) : 239 - 251
  • [48] DOSE-INTENSE 5-FLUOROURACIL IN COLORECTAL-CANCER
    CODACCIPISANELLI, G
    SEMINARA, P
    GARGANO, L
    RENZI, AR
    ARONNE, T
    FRANCHI, F
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (02) : 61 - 64
  • [49] ADJUVANT TREATMENT WITH 5-FLUOROURACIL FOR COLORECTAL-CANCER - REPLY
    FIELDING, LP
    HITTINGER, R
    GRACE, RH
    FRY, JS
    LANCET, 1992, 340 (8831): : 1349 - 1350
  • [50] Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model
    Tao, Li
    Yang, Jin-Kun
    Gu, Ying
    Zhou, Xin
    Zhao, Ai-Guang
    Zheng, Jian
    Zhu, Ying-Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (04) : 1125 - 1139